Increased CAV1 expression has been reported to be associated with progression of papillary carcinoma of the thyroid, high-grade bladder cancer, poor prognosis of pancreas cancer, and lymph node metastasis in esophageal squamous cell carcinoma. This evidence concerns the gene CAV1 and differentiated thyroid carcinoma.